share_log

HC Wainwright & Co. Maintains Buy on Olema Pharmaceuticals, Lowers Price Target to $25

Moomoo 24/7 ·  Mar 12 06:39

HC Wainwright & Co. analyst Emily Bodnar maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and lowers the price target from $28 to $25.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment